Lovell, R., Dunn, J.A., et al. (2005) Soluble Syndecan-1 Level at Diagnosis Is an Independent Prognostic Factor in Multiple Myeloma and the Extent of Fall from Diagnosis to Plateau Predicts for Overall Survival. British Journal of Haematology, 130, 542-548.
https://doi.org/10.1111/j.1365-2141.2005.05647.x

has been cited by the following article:

• TITLE: Comparison of Cell Morphology and Flow Cytometry in the Diagnosis of Multiple Myeloma

  AUTHORS: Jun Lu, Chao Li, Yong Huang, Jiakui Zhang

  KEYWORDS: Multiple Myeloma, Cell Morphology, Flow Cytometry, Immune Classification

  JOURNAL NAME: Journal of Cancer Therapy, Vol.11 No.11, November 24, 2020

  ABSTRACT: Objective: To investigate the value of cell morphology and flow cytometry in the diagnosis of Multiple myeloma (MM). Methods: 166 newly diagnosed MM patients were retrospectively analyzed, and the proportion of plasma cells detected by flow cytometry and cell morphology in these patients was statistically analyzed. Results: All patients were divided into three groups according to the proportion of plasma cells detected by cell morphology: group A (≥30%), group B (≥10% and - CD38 + CDl38 + CD56 +/- CD45dim ~ -. Conclusion: There is a certain correlation between the two detection methods. The quantitative detection of myeloma cells by cell morphology is better, and the qualitative detection by flow cytometry is better. Combined with the two detection methods, the detection rate of multiple myeloma can be significantly improved.